Creyon Bio

creyonbio.com

Creyon Bio is reinventing drug development by engineering oligonucleotide-based medicines (OBMs) for safe, precise gene-centric therapies. Utilizing powerful data sets and machine learning models, the company aims to deliver on-demand therapeutics with unprecedented speed and predictable efficacy, significantly reducing costs for new medicines. Their innovative approach allows for the treatment of diseases affecting both individual patients and larger populations, positioning Creyon Bio as a leader in the rapidly evolving field of nucleic-acid medicine.